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Ayurveda mentioned that “Doshdhatumalamoolamhi 
Shariram” i.e., the basic constituent of human body is 
Tridosha (Vata, Pitta, Kapha), Saptdhatu (Rasa, Rakta, 
Mamsa, Meda, Asthi, Majja and Sukra) and Trimala 
(Sweda, Mutra and Purish).[1] The term Dhatu is 
derived from Sanskrit root Du-Dhajya-Dharan Posanya 
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i.e., support and nourishment. Out of Saptdhatu, 
Medodhatu which is the fourth is of more clinical 
importance now-a-days because it plays a significance 
role in developing many metabolic disorders like 
Sthoulya, Prameha etc. 
Meda is present mainly in Udar but when it is present 
inside Anuasthi it is called Sarakta Meda and when in 
sthoola Asthi the same is called Majja.[2] The pure 
form of Meda present in Mamsa (Peshi) is called 
Vasa. Thus, all form of lipids in body is present mainly 
in Meda Dhatu. The transporting system to carry the 
Parinampradh Meda dhatu from the site of 
production to the site of action is Medovaha Srotas 
i.e., the channels through which the Poshak Dhatu 
passes to form the Sthayi Dhatu.  
In order to maintain the state of health it is necessary 
to have normalcy at level of Dosha, Agni, Dhatu, Mala 
along with Prasanna Indriya and Manaha.[3] When 
there is Vikruti in any of the Dhatus, whether it is 
A B S T R A C T  
The explanation of Sharir in Ayurvedic texts states that the existence of Dosha, Dhatu and Mala together is Sharir. 
Basically, there are Tridosha, Saptdhatu and Trimala. Meda is one among the Saptdhatu. The internal transport 
system which is used to carry these Dhatus (Parinampradh) is Srotas. Vitiation and depletion of Srotas can lead to 
many pathological conditions in body. If Medovaha Srotas is vitiated it will cause Medo Dushti which may be 
expressed as either Prameha Poorvaroopa or the Sthoulya Vyadhi. And in present era they are compared with 
diabetes and obesity respectively. The epidemiology of obesity and diabetes is increasing day by day and having 
serious effect on our current as well as upcoming generations. Obesity has become a worldwide epidemic, and its 
prevalence has been projected to grow by 40% in the next decade. This increasing prevalence has implications for 
the risk of diabetes, cardiovascular diseases and also for chronic kidney diseases (CKD) – CKJ OXFORD. In 2017, 
about 72 million people and 20% of the urban population were diabetic in India - international diabetes federation 
(IDF). Health service use and medical cost associated with obesity, diabetes and related diseases have risen 
dramatically and are expected to continue to grow. The above mention data necessitates throw knowledge of the 
basic concept of the Meda Dhatu, Medovaha Srotas. Thus the present study deals with the understanding of Meda 
Dhatu, Medovaha Srotas along with its Moola Sthana and the disease that may occur from its vitiation. Similar 
concept from the contemporary science have been analysed for a better understanding.  
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Pramantaha or Guntaha, then it surely effect both the 
body and the mind. According to the definition of 
Swasthya (health) it is important to have normalcy at 
the level of Dhatu. By the term Dhatu, here we 
considered both Meda and Medovaha Srotas because 
Meda Dhatu formation alone can’t perform any 
function without proper circulatory system i.e., 
Medovaha Srotas. 
Thus, clearance and obstruction of the Srotas is the 
condition of health and disease accordingly. Hence, in 
the maintenance of health the importance of Srotas is 
very obvious.[4] The disturbance in Medodhatu and 
Medavaha Srotas is very common in present era 
because of increase craving towards fast food. About 
80% of the food on the shelves of supermarket today 
didn’t exist 100 year ago – Larry Mc Caleary MD 
AIM AND OBJECTIVES 
▪ To study the concept of Meda Dhatu and 
Medovaha Srotas through Samhita Granths. 
▪ To study scientific corelation of Medovaha 
Srotomoola with that of contemporary science 
concept. 
▪ To study classical concept of Medoroga and 
Medovaha Sroto Dushti Lakshana with that of 
modern allopathic science concept (contemporary 
science). 
MATERIAL AND METHODS 
It is a conceptutal study. The material is collected 
from the classical Ayurvedic texts, modern literature 
and various research papers etc. 
REVIEW OF LITERATURE 
Meda Dhatu   
The word Meda is derived from root ‘Jihimida 
Snehana’ i.e., substance which is having the 
Snigdhatva property like- Sneha, fat, oil etc. Medyati 
Snihatiiti Meda – Shabdkalpadruma. Meda Dhatu is 
formed from the Mamsa Dhatu by the action of 
Mamsagni along with Updhatu.[5] It is composed by 
relative predominance of Jala and Prithvi 
Mahabhoota.[6] It is Derivative of Matraj Bhava. The 
Meda which is Present inside small bone is called as 
Sarakta Meda and when it is present inside the long 
bone is called Majja.[7]  
There are two type of Medo Dhatu – Poshak 
(nourishing) and Poshya (which get nourishment). 
Among these two Poshak Medodhatu is mobile in 
nature, which circulates in the whole body along with 
Rasa, Rakta Dhatu to give nutrition to Poshya 
Medodhatu. The Poshya Medodhatu which is 
immobile in nature is stored in Medodhara Kala. The 
site of Medodhara Kala is Udar and Anuasthi.[8] Udar, 
Sphik, Sthan are also depot of Poshya Medadhatu. 
Meda dhatu is the predominant Dushya in most of the 
Santarpanjanya Vyadhi like Prameha and Sthaulya.[9]  
The channels which give nutrition to the Medo Dhatu 
or the vessels carrying the nutritive material up to the 
site of Medodhatu can be considered as Medovaha 
Srotas 
Function of Medodhatu 
▪ Charaka Samhita - Asthi Pushti 
▪ Sushruta Samhita - Sneha, Sweda, Dradhatva and 
Asthi Pushti 
▪ Astanga Samgraha - Sneha, Sweda, Dradhatva, 
Asthi Pushti, Netra and Gatra Snigdhata 
▪ Bhavprakash - Sneha 
▪ Astanga Hridaya - Sneha 
Srotas  
The internal transport system of body is represented 
as Srotas. It has been given a place of fundamental 
importance in Ayurveda both in health and disease 
condition. The term Srotas is etymologically derived 
from the Sanskrit root ‘sru sravane’ i.e., to move, to 
flow, to permeate, to ooze, to filter, to exude, to 
secret, to leak. According to Acharya Charaka, Strotas 
is defined as the channel or structure through which 
Sravanam i.e., oozing, moving and permeation of 
different constituents and nutrients takes place.[10] 
Again, it is described as channels of circulation that 
transport the Dhatus which are constantly subjected 
to metabolic transformation 
(Parinamamapdyamananam).[11] They work as 
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communicating channels for nutrient tissues (Asthayi 
Dhatus) which are to be utilized for formation of 
permanent Dhatus (Sthayi Dhatus). 
Acharya Sushruta describes that Srotas are the 
channels of the body having originated from organ 
cavity i.e., Khadantarm spread throughout the body 
excluding Sira and Dhamani.[12] 
Acharya Vagbhat compared Srotas to the extremely 
fine passages and pores present in the lotus stem. He 
observes, “Rasa spreads throughout the body through 
very fine dwaras (pores) of Srotamsi which are 
distributed extensively in the body, very much like 
minute channels, present in the lotus stem.” [13] 
According to Chakrapanidatta Srotas are the channel 
which serves as vehicles of transport of both Prasad 
and Mala Dhatus and also serve as the place of their 
entry (or exit). 
Dalhana the commentator of Sushruta Samhita has 
described that all the structures through which Prana, 
Anna, Udaka, Rasa, Rakta, Mansa, Meda etc. circulate 
are called Srotas. 
In short according to contemporary science we can 
consider Srotasas as the micro and macro channels of 
circulations and pathways, carrying out all the 
physiological functions of the body. They carry solid, 
liquid and gaseous type of substances, nerve 
impulses, nutrients, secretions, enzymes, hormones, 
waste product etc. in and out of the system. 
The healthy and diseased condition of the body 
depends on proper structure and function of these 
macro and micro channels. As long as these channels 
of circulations perform their normal functions, the 
body is void of diseases.[14] 
Swaroopa (characteristics and qualities) of Srotas  
The Srotas has the colour of the Dhatu (tissue) that 
they are carrying or transporting. They are of different 
shapes and sizes viz, round, thick, large, small, 
microscopic, elongated and form network and 
branches.[15]  With this description, each and every cell 
can be considered as a Srotas since the transportation 
mechanism occurs within the cell and between cells. 
Types of Srotas  
Bahirmukha Srotas [16] – They are nine in male and 
twelve in female. Netra – 2, Karna – 2, Nasa – 1, 
Mukha – 1, Guda – 1, Medhra – 1. In female’s Yoni – 1 
and Stana - 2  
Antarmukha Srotas   
Srotas described in Charaka Samhita 
▪ Pranavaha Srotas 
▪ Udakvaha Srotas 
▪ Annavaha Srotas 
▪ Rasavaha Srotas 
▪ Raktavaha Srotas 
▪ Mamsavaha Srotas  
▪ Medovaha Srotas 
▪ Asthivaha Srotas 
▪ Majjavaha Srotas 
▪ Shukravaha   Srotas  
▪ Mutravaha   Srotas 
▪ Swedavaha Srotas  
▪ Purishavaha Srotas. 
Srotas described in Sushruta Samhita 
▪ Pranavaha Srotas    
▪ Annavaha Srotas  
▪ Udakvaha Srotas    
▪ Rasavaha Srotas  
▪ Raktavaha Srotas    
▪ Mansavaha Srotas  
▪ Medovaha Srotas    
▪ Mutravaha Srotas  
▪ Purishavaha Srotas                              
▪ Shukravaha Srotas  
▪ Artavavaha Srotas  
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Medovaha Srotas  
Dhatu are nourished through their respective 
Srotasas. The Medodhatu gets its nutrition from the 
Srotas called Medovaha Srotas. As per Dr. C 
Dwarkanath, the channels through which nutrition to 
the adipose tissue is transported are to be termed as 
the Medovaha Srotas. Dr Ghanekar B G considered 
the Medovaha Srotas as the capillaries of the 
perinephric tissue and omentum. 
Concept of Moolasthana  
In classical Ayurvedic texts concept of Moolasthana is 
focused. Although they have different opinion 
regarding Moolasthana, they considered it to be 
Prabhavasthanam i.e., from where all the activities of 
that particular Srotas take place and also which is 
affected most during pathological conditions. 
Moolamiti Prabhavasthanam is explains by the 
commentator of Charaka Samhita Acharya 
Chakrapani - ‘If root of the tree is destroyed, it will 
cause harm to the whole tree. Likewise, if harm is 
caused to Srotomoola, it will lead to damage to whole 
srotas.[17] 
Moolasthana  
The Medovaha Srotomoola means the organ which 
may be closely related to Medodhatu functions or 
which are important sites related to beginning or 
ending of the channels of Medodhatu. 
Vrikka  
One of the Koshtanga formed by the Sara of Rakta 
and Medodhatu.[18] According to Dalhana 
commentator of Sushruta Samhita stated that Vrikka 
looks like Mamsapinda and are two in number which 
are situates in left and right side of the quadrum.[19] 
By the word Parshva he probably means 
retroperitoneal situation. Acharya Sharangadhara 
stated that Vrikka nourishes the Medodhatu of the 
Jatharpradesh.[20] 
The upper part of the kidney – supra renal gland, 
which control the secretion of epinephrine and non-
epinephrine hormones actively participate in the 
breakdown process of the triglyceride. 
Kidney does not filter the lipids. Kidney protects the 
lipids but the fact that filtration of fat does not occur 
and protections of lipids through kidney enhance fat 
in the body. This type of action is not seen with 
protein and carbohydrate, they are filtered and 
absorbed. Kidney is set to give special importance to 
lipids. If kidney will not filter urea the increase blood 
urea would have been cause inhibition of fat 
deposition. Approving the fact that it strengthens and 
built fat deposition in the body especially abdomen, 
which exactly is said by Acharya Sharangadhara. The 
other point to be considered is – hormones from 
adrenal cortex and medulla influence lipid 
metabolism. Glucocorticoids from adrenal cortex 
influence fat metabolism by influencing sterol 
metabolism and adipose tissue synthesis.[21] 
Vapavahan  
It is mentioned as Koshtanga and Moolasthana of 
Medovaha Srotas. Vapavahan means the transporter 
or carrier of Vapa (fat). Acharya Chakrapani has 
considered it as Tailavartika while Dr. Ghanekar has 
considered it as omentum, where the maximum Meda 
is stored. 
Omentum is appeared as a thin fenestrated 
membrane with varying amount of fat deposition. The 
size of omentum varies from individual to individual. It 
is composed of two mesothelial sheets which enclose 
predominantly adipocytes embedded in a loose 
connective tissue. This adipose tissue plays an 
important immune role but can also serve as a source 
of chronic inflammation in obese individual possibly 
contributing to metabolic syndrome.[22]  
Kati   
Kati is the region where large amount of fat 
deposition occurs. In modern it is corelated with loan 
region whose exact side is lower part of back between 
Acharya Moolasthana 
Acharya Charaka Vrikka and Vapavahan 
Acharya Sushruta Vrikka and Kati 
Acharya Vagbhat Vrikka and Mamsa  
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the ribs and pelvic according to Taber’s Cyclopedia 
medical Dictionary. 
These days waist circumference – height ratio (WHtR) 
is recommended in screening cardiometabolic 
syndrome. Also, a number of studies on WHtR, WC 
and BMI have been proved valuable in prediction 
various metabolic syndromes like obesity, DM etc.[23] 
Mamsa 
Acharya Vagbhat has considered Mamsa as 
moolasthana of Medovaha Srotas. The probable 
reason may be due to its physiological role. Muscles, 
especially the skeletal muscles are known to store fat 
(IMCL- Intramyocellular Lipids).   
Clinical Significance   
Meda Dhatu Dushti Lakshana  



































Mamsa, Rakta Vikara 
Medovahsroto Dushti and Sroto Viddha Lakshana  
Acharya Charka has described Srotodushti Lakshana 
while Acharya Sushruta has explained Srotoviddha 
Lakshana 














Atidheerga (excessive tallness) 
Atiharshva (dwarfism) 
Atiloma (excessive hairs) 
Aloma (lack of body hairs) 
Atikrishna (extreme dark colour) 











As per Acharya Sushruta by the study of a single 
Shastra, a man can never catch the true importance of 
this (science of medicine). Therefore, a physician 
should study as many as allied branches related with 
this science. Hence, to understand the concept of 
Moolasthana lets throw some tight on modern 
literature.[24] 
Swedagmana - Adrenal gland disorder can cause the 
adrenal medulla to produce increased level of 
epinephrine and norepinephrine. These hormones act 
on the sympathetic nervous system, leading to 
excessive sweating. 
Swasa - Numerous respiratory complications are 
associated with obesity. Obese individual has an 
increase demand for ventilation and breathing 
workload, respiratory muscle insufficiency, decreased 
functional reserve capacity and respiratory reserve 
volume and closure of peripheral lung units. Obesity is 
a classical cause of alveolar hypoventilation.[25]   
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Taalu Sosha - The sensation of dry mouth including 
palate will occur when the salivary flow rate is less 
than the rate of water absorption from the mouth. A 
dry mouth is a symptom as well as cause of high blood 
sugar. 
Pipasa - The cause of Pipasa is may be due to 
decrease blood volume without reducing the 
intracellular fluid. The decreased blood volume is 
distinguished by cells in the kidney and elicits thirst 
for both water and salt via the rennin-angiotensin 
mechanism. 
Sopha - Abnormal and excessive accumulation of free 
fluid in the interstitial tissue space and serous cavities. 
Extra renal mechanism involves the secretion of 
aldosterone, a sodium retaining hormone by the renin 
angiotensin aldosterone system 
Sthoulya - In obeys individual two distinct phenotypes 
are apparent – generalised obesity and abdominal 
obesity. Of this abdominal obesity is strong indicator 
for development of coronary artery disease, insulin 
resistance and consequently type -2 diabetes mellitus 
and many comorbid conditions.[26] 
A BMI between 18.5 and 25 kg/m2 is considered by 
the World Health Organization (WHO) to be normal 
weight, a BMI between 25 and 30 kg/m2 as 
overweight, and a BMI of>30 kg/m2 as obese. 
Alternative parameters to more accurately capture 
visceral fat include waist circumference (WC) and a 
waist hip ratio (WHR) of >102cm and 0.9, respectively, 
for men and >88cm and >0.8, respectively, for 
women. WHR has been shown to be superior to BMI 
for the correct classification of obesity in CKD. 
Obesity has become a worldwide epidemic, and its 
prevalence has been projected to grow by 40% in the 
next decade. This increasing prevalence has 
implications for the risk of diabetes, cardiovascular 
diseases and also for chronic kidney diseases (CKD) – 
CKJ OXFORD. This increasing prevalence of obesity has 
implications for cardiovascular disease (CVD) and also 
for CKD. A high BMI is one of the strongest risk factors 
for new-onset CKD.[27] 
Prameha - In 2017, about 72 million people (8.8% of 
the total population having age 18 years or above) 
and 20% of the urban population was diabetic in India 
(International Diabetes Federation (IDF).[28] According 
to Diabetes Foundation of India, people suffering from 
diabetes are likely to go up to 80 million by 2025, 
making India the ‘Diabetes Capital’ of the world.[29] 
Over nutrition has been found to be a major risk 
factor for a number of diseases such as diabetes, 
hypertension, heart diseases, certain type of cancers, 
etc.[30] Huffman et al consider a cohort sample of 1100 
women in South Delhi and show that an increase in 
BMI has a statistically significant impact on diabetes 
among married women in Delhi, India.[31] The study by 
Ramachandran et al. finds a positive association 
between diabetes and BMI for the urban population 
across six cities in India using the National Urban 
Diabetes Survey.[32] 
DISCUSSION 
In metabolic syndrome, the abnormal Meda, when 
deposited into subcutaneous tissue, it gives the 
clinical presentation of obesity and similarly  when 
Abaddha Meda extracted to Basti it creates the 
manifestation of Prameha and when this Meda is 
unnaturally deposited in the arterial wall and increase 
the peripheral resistance 
(Dhamnipratichaya/arteriosclerosis) it shows clinical 
manifestations like HTN and when these unnatural 
Meda present in the Rakta Vaha Srotas leads to 
increase level of unwanted fat level - 
hypercholesterolemia. The formation of Meda not 
only depends on over consumption but also due to 
less utilization. The modern life style makes the 
human being more comfortable.  
The management of disease caused due to vitiation of 
Medovaha Srotas should be done on the basis of line 
of treatment of Medo Roga.[33] Nidana Parivarjana, 
Samshaman and Samsodhana Chikitsa should be 
done. In the treatment of obesity Guru Aptarpana 
should be done. And in the treatment of Prameha it is 
said that - The basic concept of utilization of excess 
energy should be done through physical exercise. It is 
mention by Acharya Sushruta that – walking without 
rest for a distance of hundred Yojana, is one of the 
best remedies for Sthula Pramehi. 
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The same management criteria which have been 
described by our Acharyas hundreds of year back has 
been proven scientifically now a days on the basis of 
modern research which the world is obeying. The 
following are the few examples- 
In overweight or obese diabetic patients, a lifestyle 
intervention including caloric restriction and increased 
physical activity compared with a standard follow up 
based on education and support to sustain diabetes 
treatment reduced the risk for incident CKD by 
30%.[34] 
In a recent meta-analysis collating experimental 
studies in obese CKD patients, interventions aimed at 
reducing body weight showed coherent reductions in 
blood pressure, glomerular hyper-filtration and 
proteinuria.[35] 
Globally, these experimental findings provide a proof 
of concept for the usefulness of weight reduction 
interventions in the treatment of CKD in the obese.[36]   
Population-wide interventions to control obesity 
could have beneficial effects in preventing the 
development, or delaying the progression, of CKD, 
CVD, and DM etc. It is incumbent upon the entire 
healthcare community to devise long-ranging 
strategies toward improving the understanding of the 
links between obesity and related diseases, and to 
determine optimal strategies to stem the tide. 
The original alarm was sounded in 1994 by the 
National Centre for Health Statistics when they 
reported their data from the first 3 years of the 
National Health and Nutrition Examination Survey 
(NHANES). The authors observed that from 1988–
1994 (NHANES III) to NHANES 1999–2000, the 
prevalence of overweight in adults increased from 
55.9% to 64.5%. During that same period, the 
prevalence of obesity increased from 22.9% to 30.5%. 
This sudden, unanticipated jump in the prevalence of 
obesity led the American Heart Association (AHA) to 
call for action to curb the consequences of this 
epidemic.[37, 38] More recently the AHA has addressed 
and reviewed a variety of weight loss approaches for 
the management and treatment of obesity.[39]  
CONCLUSION 
On the basis of the above facts, it may be concluded 
that assessment of Moolasthana of Medovaha Srotas 
and scientifically consideration of Moola Sthana of 
Medovaha Srotas i.e., Vrikka, Vapavahan, Mamsa and 
Kati is true scientific explanation. The two Vrikka are 
the Moola of Medovaha Srotas located in the Kostha 
near the Prustavansh same as kidney within the 
paranephric fat present in the posterior abdominal 
cavity parallel to vertebral column. Vapavahan can be 
correlated with omentum as it is present in Udar 
where the excess amount of Meda (triglyceride) is 
stored. Kati is the area same as lumbar region, where 
storage of Meda (triglyceride) takes place. 
The fact that the intra- abdominal adipocyte is more 
lypolytically active than those from other depots. This 
mechanism is vivid in the mind of our acharyas. 
Hence, they considered the depots of intra-abdominal 
fat as the Moola Sthana of Medovaha Srotas 
considering Vrikka, Vapavahan, Kati and Mamsa. The 
concept of Sroto vitiation and management which has 
been explained in our texts thousands of years back 
are being scientifically proven by the contemporary 
medical science in the form of researches and 
statistically calculated results. Thus, complete 
knowledge of Srotas is must for an Ayurvedic 
Physician to approach a patient in a holistic way and 
to cure the disease from its roots.       
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